Global private equity and venture capital news and research

Posts Tagged ‘Essex Woodlands Health Ventures.’

3 January 2014

Venture capital-backed Revance eyes Nasdaq IPO

stock brokerage market share listed Venture capital-backed biopharmaceutical company Revance Therapeutics is looking to raise $86.25m via an IPO on the Nasdaq exchange.

2 May 2013

Danish biopharma Symphogen secures €141m from existing investors

Danish biopharmaceutical company Symphogen has closed an expansion of its previously announced €100m financing, securing a €141m placement of preferred stock to a group of existing investors.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016